BioNTech SE (BNTX) Return on Invested Capital (2019 - 2025)

BioNTech SE (BNTX) has 7 years of Return on Invested Capital data on file, last reported at 0.01% in Q4 2025.

• In Q4 2025, Return on Invested Capital rose 1.0% year-over-year to 0.01%; the TTM figure through Dec 2025 stood at 0.01% (up 1.0% YoY), while the FY2022 annual figure was 0.01%, changed 0.0% from the prior year.
• Return on Invested Capital retreated to 0.01% in Q4 2025, from 0.01% in the prior quarter.
• Across five years, Return on Invested Capital topped out at 7837.89% in Q3 2021 and bottomed at 0.02% in Q4 2024.
• A 5-year average of 869.86% and a median of 0.01% in 2023 frame the typical range for Return on Invested Capital.
• Annual changes were most pronounced in 2021 — Return on Invested Capital soared 642975 bps — and 2022, when it sank 783788 bps.
• Year by year, Return on Invested Capital stood at 0.03% in 2021, then sank by 70 bps to 0.01% in 2022, then slipped by 29 bps to 0.01% in 2023, then tumbled by 528 bps to 0.02% in 2024, then jumped by 60 bps to 0.01% in 2025.
• The last three Return on Invested Capital figures came in at 0.01% (Q4 2025), 0.01% (Q3 2025), and 0.01% (Q2 2025), per Business Quant data.

Peer Comparison